Results 161 to 170 of about 163,060 (262)
A case of lysozyme-induced nephropathy with improved renal function following treatment for chronic myelomonocytic leukemia. [PDF]
Nukui N +6 more
europepmc +1 more source
Regulatory harmonization: Evolution, globalization and future directions
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm +2 more
wiley +1 more source
NSG-S mice for acute myeloid leukemia, yes. For myelodysplastic syndrome, no
Emmanuel Griessinger, Michael Andreeff
doaj +1 more source
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga +2 more
wiley +1 more source
ABSTRACT The continuous capture process, with its benefits of enhanced productivity, resin utilization, and reduced footprint, has significantly saved costs. Due to the complexity of three‐column periodic counter‐current chromatography (3 C‐PCC), a represented 3‐column scale‐down model (SDM) based on conventional ÄKTA equipment is still absent for ...
Yuqi Du +11 more
wiley +1 more source
Research progress on the BAG3-HSP70 axis-mediated autophagy in acute myeloid leukemia. [PDF]
Liu Y, Wu T.
europepmc +1 more source
ABSTRACT Monoclonal antibody downstream processing often requires multiple pH adjustments between Protein A capture and polishing steps. These adjustments increase process complexity and make direct unit‐operation connection more difficult. We evaluated a connected post‐capture polishing block operated at approximately pH 5.0 using mild‐pH Protein A ...
Takaki Aiso +5 more
wiley +1 more source
Tackling cancer stemness with nanotechnology in the era of precision medicine
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo +9 more
wiley +1 more source
Case Report: Acute monocytic leukemia mimicking large-vessel vasculitis on <sup>18</sup>F-FDG PET/CT. [PDF]
Nie L, Wang H, Shen N, Han Y.
europepmc +1 more source
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang +8 more
wiley +1 more source

